# Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

> **NCT03175029** · PHASE2 · COMPLETED · sponsor: **Taiho Pharmaceutical Co., Ltd.** · enrollment: 195 (actual)

## Conditions studied

- Detrusor Underactivity
- Overactive Bladder

## Interventions

- **DRUG:** TAC-302
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03175029
- **Lead sponsor:** Taiho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-09
- **Primary completion:** 2019-11-01
- **Final completion:** 2020-03-27
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03175029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03175029, "Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03175029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*